Global Blood Screening Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Blood Screening Market Analysis

  • Medical Devices
  • Upcoming Report
  • Dec 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Frequently Asked Questions

Blood Screening Market to grow at a CAGR of 5.75% by forecast 2029.
North America region holds the largest share in the market.
The countries covered in the blood screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Major players operating in the blood screening market report are Enzo Biochem Inc., meridianbioscience., BD, Bio-Rad Laboratories, Inc., Thermo Fisher., BioMérieux SA, Beckman Coulter, Inc., Abbott, F. Hoffmann-La Roche Ltd, Cepheid, GENERAL ELECTRIC, Digirad Corporation., Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, GRIFOLS INTERNATIONAL, S.A., Siemens, Ortho Clinical Diagnostics, Immucor., and Hologic Inc.